Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H20N2O |
| Molecular Weight | 232.3214 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC2=C(NC(C)=C2CCN(C)C)C=C1
InChI
InChIKey=ACEHBQPPDDGCGZ-UHFFFAOYSA-N
InChI=1S/C14H20N2O/c1-10-12(7-8-16(2)3)13-9-11(17-4)5-6-14(13)15-10/h5-6,9,15H,7-8H2,1-4H3
| Molecular Formula | C14H20N2O |
| Molecular Weight | 232.3214 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 23:08:24 GMT 2025
by
admin
on
Mon Mar 31 23:08:24 GMT 2025
|
| Record UNII |
XZ2CCP18I2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
TiHKAL
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-5-MeO-TMT
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5-MeO-2-TMT
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
PRIMARY | 5-Methoxy-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT, 5-MeO-TMT) is a psychoactive drug of the tryptamine chemical class which acts as a psychedelic. It was first synthesized by Alexander Shulgin and reported in his book TiHKAL ("Tryptamines i Have Known And Loved").[1] 5-MeO-TMT is claimed to show psychoactive effects at a dosage of 75-150 mg orally, but these are relatively mild compared to those of other similar compounds. This suggests that while the methyl group on the 2-position of the molecule has impaired the binding of metabolic enzymes like monoamine oxidase (MAO), it is also interfering with binding to and/or activation of the serotonin 5-HT2A receptor, the target responsible for mediating the hallucinogenic effects of such compounds. | ||
|
XZ2CCP18I2
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
PRIMARY | |||
|
49756
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
PRIMARY | |||
|
DTXSID10217627
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
PRIMARY | |||
|
67292-68-6
Created by
admin on Mon Mar 31 23:08:24 GMT 2025 , Edited by admin on Mon Mar 31 23:08:24 GMT 2025
|
PRIMARY |